Who we are
Our mission is to serve our clients’ needs through timely, thorough, creative and innovative representation. Our clients and their employees are customers we appreciate and they deserve a salute, a smile and service that “wows” them.
Contact me, Bill Broydrick today at 414-719-1399, or firstname.lastname@example.org.
What’s the buzz …
Welcome to Client: Munger Farms
We are assisting Munger Farms in clarifying the current regulation on what constitutes organic production. Munger is the largest blueberry grower in America based on the West Coast with locations in California, Oregon, and Washington
As of the most recent update to TRICARE’s preventive services policies, Exact Science’s Cologuard – the most effective, non-invasive colorectal cancer screening exam – is now given first-dollar coverage for 9.4 million active-duty, reserve, and National Guard personnel, veterans, and their dependents. The revision brings TRICARE into compliance with the most recent United States Preventive Services Task Force (USPSTF) colorectal cancer screening recommendations that include Cologuard as an A-rated option for preventive care. (Click heading to read more).
As of two days ago Exact Sciences’ Cologuard – the most effective, non-invasive colorectal cancer screening exam – is now included in the National Committee for Quality Assurance’s (NCQA) Healthcare Effectiveness Data and Information Set (HEDIS). Inclusion in HEDIS means that physicians will receive quality credit for providing patients an exam given an “A” rating by the United States Preventative Services Taskforce (USPSTF). Earning quality credits is part of the overall movement towards Value Based Purchasing (VBP) that entitles providers to bonuses based on quality improvement. We applaud NCQA for its decision, marking a reaffirmation of our nation’s commitment to fight colorectal cancer – the second leading cause of cancer deaths in America.
The decision marks yet another milestone for Cologuard on its path to nationwide, first-dollar coverage that already includes becoming the first product ever to simultaneously receive FDA approval and a Medicare coverage decision, A-rated by the USPSTF, and affirmed by Medicare Advantage.
Congratulations to our client Poly-Technical Solutions, LTD!!
On Friday, EPA approved their application for a new nano-technology anti-microbial. It is a breakthrough innovation with wide applications and great commercial potential. Essentially it kills bacteria, fungi and viruses making clothing and many other materials including plastic self-cleaning.
Broydrick and Associates has represented them since December 2014. They first applied to EPA in 2009. We are happy and proud that we helped them win!
Yesterday Exact Sciences sponsored a very successful Congressional Staff briefing on Innovation in Cancer Detection.
Exact Sciences has gained FDA and Medicare approval for Cologuard a non-invasive colon cancer screening test that detects 92% of colon cancer and 69% of advanced pre-cancer.
Read more on Bill’s Blog
Another Victory! Victory on Liver Donation Controversy